These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6445324)

  • 1. Suppression of rejection of organ allografts by alloantibody.
    Morris PJ
    Immunol Rev; 1980; 49():93-125. PubMed ID: 6445324
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of rat renal allograft rejection by antigen and antibody.
    Stuart FP; McKearn TJ; Weiss A; Fitch FW
    Immunol Rev; 1980; 49():127-65. PubMed ID: 6989746
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of antibodies in the rejection and enhancement of organ allografts.?7318.
    Carpenter CB; d'Apice AJ; Abbas AK
    Adv Immunol; 1976; 22():1-65. PubMed ID: 769500
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of rejection and prolongation of vascularized organ allografts.
    Tilney NL; Kupiec-Weglinski JW; Heidecke CD; Lear PA; Strom TB
    Immunol Rev; 1984; 77():185-216. PubMed ID: 6232201
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperacute rejection of skin allografts in the mouse by the administration of alloantibody and rabbit complement.
    Koene RA; Gerlag PG; Hagemann JF; van Haelst UJ; Wijdeveld PG
    J Immunol; 1973 Aug; 111(2):520-6. PubMed ID: 4577882
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological enhancement of renal allografts.
    Stuart FP; McKearn TJ; Fitch FW
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):53-8. PubMed ID: 4140597
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolonged survival of renal allografts in outbred rabbits treated with donor specific F(ab')2 alloantibody.
    Sutherland DE; Howard RJ; Dombrovskis S; Najarian JS
    Ann Surg; 1974 Dec; 180(6):857-63. PubMed ID: 4611361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody titres of antilymphocytic sera and globulins determined by immunofluorescence and their correlation with immunosuppressive activity.
    Thomas D; Woodrooffe JG; Mosedale B; Ward PD; Zola H; Edwards DC; Balner H
    Clin Exp Immunol; 1972 Aug; 11(4):569-78. PubMed ID: 4628577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of the rat alloimmune response by enhancing antibodies and the role of blocking factors in the survival of renal grafts.
    Strom TB; Carpenter CB; Garovoy MR; Abbas AK; Corson JM; Bear RA; Soulillou JP
    Transplantation; 1975 Nov; 20(5):368-80. PubMed ID: 1108311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of "high" and "low" doses of humoral antibodies on allotransplanted tissue in inbred rats.
    Ishikawa M
    Transplantation; 1981 May; 31(5):402-3. PubMed ID: 7015631
    [No Abstract]   [Full Text] [Related]  

  • 11. Abrogation of T cell homing by alloantibody.
    Chang AE; Sugarbaker PH
    Transplantation; 1980 Feb; 29(2):127-32. PubMed ID: 6986686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing alloantibody effective during sensitization but not effector phase of skin graft rejection.
    Sugarbaker PH; Chang AE
    Transplantation; 1979 Jul; 28(1):60-5. PubMed ID: 377597
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of cyclosporin A with antilymphocyte serum and with enhancing serum for the suppression of renal allograft rejection in the rat.
    Homan WP; Fabre JW; Millard PR; Morris PJ
    Transplantation; 1980 Mar; 29(3):219-22. PubMed ID: 6987786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro correlates of rejection. I. Suppressive effect and specificity in mixed lymphocyte interaction of alloantiserum producing hyperacute rejection.
    Guttmann RD
    Transplant Proc; 1977 Mar; 9(1):755-60. PubMed ID: 68601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of pepsin-digested donor specific alloantibody to prolong renal allograft survival in dogs.
    Callender CO; Sutherland DE; Howard RJ; Toledo-Pereyra LH; Najarian JS
    Immunol Commun; 1974; 3(4):309-19. PubMed ID: 4618546
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the specific suppression of renal allograft rejection in presensitised rats. Theoretical and clinical implications.
    Fabre JW; Morris PJ
    Transplantation; 1975 Feb; 19(2):121-33. PubMed ID: 1091037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced immune destruction of long-surviving, H-2 incompatible kidney transplants in mice.
    Russell PS; Chase CM; Colvin RB; Plate JM
    J Exp Med; 1978 May; 147(5):1469-86. PubMed ID: 349112
    [No Abstract]   [Full Text] [Related]  

  • 19. Passive enhancement of homozygous renal allografts in the rat.
    Fabre JW; Morris PJ
    Transplantation; 1974 Nov; 18(5):429-35. PubMed ID: 4610921
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppression in rabbits: skin and kidney allografts.
    Green CJ
    Lab Anim; 1975 Jul; 9(3):223-32. PubMed ID: 1099335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.